A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
Crossref DOI link: https://doi.org/10.1007/s12274-014-0635-4
Published Online: 2014-12-03
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shahbazi, Mohammad-Ali
Shrestha, Neha
Mäkilä, Ermei
Araújo, Francisca
Correia, Alexandra
Ramos, Tomás
Sarmento, Bruno
Salonen, Jarno
Hirvonen, Jouni
Santos, Hélder A.
Text and Data Mining valid from 2014-12-03